関連する実験動画
Updated: Jan 28, 2026
11:19
Guidelines for Elective Pediatric Fiberoptic Intubation
Published on: January 17, 2011
18.5K
後天性小児甲状腺機能低下症の解明
Mariacarolina Salerno1,2, Donatella Capalbo1,3, Mariella Valenzise4
1Department of Translational Medical Sciences, Pediatric Endocrinology Unit, University of Naples Federico II, Naples, Italy.
Frontiers in endocrinology
|January 26, 2026
まとめ
橋本病が原因であることが多い小児の後天性甲状腺機能低下症は、多様な症状を呈します。小児患者の最適な成長と発達のためには、早期診断と管理が重要です。
科学分野:
- 小児内分泌学
- 内科学
- 臨床症例レビュー
背景:
- 後天性甲状腺機能低下症は、小児における最も一般的な甲状腺疾患です。
- 橋本病は、ヨウ素が十分な地域における主な原因です。
- 臨床症状は様々であり、診断を複雑にし、発達に影響を与える可能性があります。
研究 の 目的:
- 小児の後天性甲状腺機能低下症に関する現在の知識を要約すること。
- 実例の小児症例を通して、典型的および非典型的な症状を例示すること。
- 小児科医が小児の甲状腺機能低下症を特定し、管理するのを支援すること。
主な方法:
- 後天性甲状腺機能低下症の4人の小児症例のレビュー。
- 病因、臨床症状、診断、および管理の包括的な概要。
- 小児の後天性甲状腺機能低下症に関する文献の統合。
主要な成果:
- 提示された症例は、後天性甲状腺機能低下症の典型的および非典型的な兆候を示しました。
- 多様な提示は、診断上の課題を強調しています。
- 小児の予後にとって、タイムリーな介入が重要です。
結論:
- 後天性甲状腺機能低下症は、小児において注意深い診断を必要とします。
- 多様な症状を理解することは、小児科医に役立ちます。
- 効果的な管理は、成長および発達への悪影響を防ぐために不可欠です。
関連する概念動画
01:26Pharmacokinetics in Pediatric Patients: Drug Excretion
225
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
225
01:17Pharmacokinetics in Pediatric Patients: Drug Distribution
285
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
285
01:24Pharmacokinetics in Pediatric Patients: Drug Metabolism
212
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
212
01:23Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
271
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
271
01:20Monohybrid Crosses
239.3K
Overview
239.3K
02:58Regulated Protein Degradation
8.8K
It is vital to regulate the activity of enzymatic as well as non-enzymatic proteins inside the cell. This can be achieved either through creating a balance between their rate of synthesis and degradation or regulating the intrinsic activity of the protein. Both these regulation mechanisms play an essential role in the normal functioning of cells.
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
8.8K